Infliximab


( Last Updated : May 30, 2014)
Generic Name:
Infliximab
Project Status:
Withdrawn
Therapeutic Area:
Ankylosing spondylitis; arthritis, psoriatic; arthritis, rheumatoid; plaque psoriasis
Manufacturer:
Fresenius Kabi Canada
Call for patient/clinician input open:
Brand Name:
Remsima
Project Line:
Reimbursement Review
Project Number:
SE0383-000
Call for patient/clinician input closed:

Details


Biosimilar:
Yes
Submission Type:
Initial
Indications:
Ankylosing spondylitis, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis